PPD uses cookies on this website. Please be aware that if you continue browsing the website without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.
Find out how PPD’s clinical development services can help advance drug research and development for your product.
Experience across a broad range of indications and an investigator network of more than 6,000 cardiologists.
PPD's Phase I Clinic conducts clinical studies to determine how new medicines act in the bodies of healthy volunteers.
Get information about PPD posted on industry websites and publications.
Urinary incontinence is a compelling and promising area in clinical development that can address many unmet needs in women and the aging population. Research within the next decade is well-positioned to successfully develop new treatments.
PPD has the medical, clinical development and operational expertise to understand intricacies of this therapeutic area and support successful clinical development in urinary incontinence indications.
To download the white paper, please complete the form below. Fields marked with * are required. Pharmaceutical Product Development, LLC and its affiliates (together “PPD”) will use the information you provide on this page for the purposes of sending you the requested white paper and possibly following up with you. Important information on how PPD handles personal data and what rights you may have under data privacy laws are included within PPD’s Global Privacy Policy.
We want to hear from you
Register in PPD's Database
RSS Twitter LinkedIn Facebook
© 2019 Pharmaceutical Product Development, LLC. All rights reserved.